Clinical Fellow – Stereotactic Ablative Body Radiotherapy

NHS; Manchester; On-site; GBP 40,000 - 55,000; Full time

Job summary

A leading cancer treatment center in Manchester seeks a Clinical Fellow for a 12-month position in Clinical Oncology. You will work alongside consultants to develop Stereotactic Ablative Body Radiotherapy (SABR) techniques and manage patients. This role involves patient assessments, treatment planning, and contributing to clinical research. The ideal candidate has a full FRCR and experience in SABR and multidisciplinary teamwork.

Qualifications

• Minimum three years post full registration in General Medicine.
• Completed a minimum of 3 years Clinical Oncology training.
• Understanding of audit principles.

Responsibilities

• Manage patients with HBT and oligometastatic disease.
• Screen referrals and participate in MDT.
• Supervise Technical Radiotherapy delivery.

Skills

Research awareness

Participation in multidisciplinary teams

SABR experience

Education

MB BCh or Equivalent; full FRCR (UK)

Job description

Overview

Applications are welcomed for a 12 month SABR clinical fellow post commencing December 2025 in Clinical Oncology, based at The Christie NHS FT, Manchester, UK Europe's largest single site cancer hospital.

This post is for 40 hours per week as a Clinical Fellow for the development and implementation of Stereotactic Ablative Body Radiotherapy (SABR) within the organisation for a fixed term period of 12 months with the option to extend for up to a further 12 months. The post holder will be employed by The Christie NHS Foundation Trust and will be based at The Christie. The successful applicant would be expected to work alongside consultants and trainees in out-patient clinics, supervising Technical Radiotherapy delivery and performing on-treatment reviews and follow-up assessments.

Main duties of the job

The post holder will be involved in all aspects of the management of patients with HBT and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated SABR team consultant.

They will be expected to teach junior medical staff, medical students and nurses on occasion.

They will be expected to take part in audit and research.

There is no on call responsibility with this post.

About us

The Christie is one of Europe\'s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country. We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years. We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.

Responsibilities

The successful applicant would be expected to work alongside consultants and trainees in outpatient clinics across a number of disease groups, supervising Technical Radiotherapy delivery and performing on-treatment reviews and follow-up assessments. The role will be responsible for: The appointee will be a Fellow in the department of Clinical Oncology. The employing authority is The Christie NHS Foundation Trust. S/he will be managerially accountable to the Clinical Director of the Directorate of Clinical Oncology. S/he will be professionally responsible to the consultants in whose clinics s/he will be supporting. The post-holder will be assigned a clinical supervisor (Consultant Clinical Oncologist). They will work alongside their supervisor in at least one clinic. Will develop expertise in the development, management and treatment of HPB and oligometastatic tumour sites with SABR.

The Clinical Oncology establishment currently consists of 59 Consultants who run the clinical service and research practice. There is also a team of 24 SpRs plus Academic and Clinical Fellows.

The appointee will be based at The Christie and will provide senior input to all aspects of the management of patients with HBT and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated SABR team consultant.

Person Specification

• MB BCh or Equivalent; full FRCR (UK)
• Research awareness
• Evidence of enthusiasm and participation in research

Experience

• At least three years post full registration in General Medicine. Completed a minimum 3 years Clinical Oncology training
• Understands principles of audit.
• Ability and willingness to work in multidisciplinary teams
• Previous SABR experience
• Evidence of participation in audit
• Skills in time/resource management

Teaching

• Evidence of teaching and involvement in the education of medical students/junior doctors

Personal Skills

• Awareness of development needs and desire to achieve this through evidenced based appraisal.
• Developing Leadership Awareness
• Ambition to become an autonomous practitioner (development/CESR/Specialist)

Disclosure and Barring Service Check

This post is subject to the Rehabilitation of Offenders Act (Exceptions Order) 1975 and as such it will be necessary for a submission for Disclosure to be made to the Disclosure and Barring Service (formerly known as CRB) to check for any previous criminal convictions.